Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Granulomatosis with Polyangiitis Rates & Outcomes

Ruth Jessen Hickman, MD  |  Issue: October 2018  |  October 18, 2018

Designua / shutterstock.com

Designua / shutterstock.com

A recent study in Arthritis & Rheumatology highlights new information about the epidemiology and disease course of the vasculitic disease granulomatosis with polyangiitis (GPA, formerly known as Wegener’s disease).1 GPA is a rare disease that’s generally specific to the lungs, kidneys and the upper airways. The study provides key new data about the incidence and prevalence of the disease in the U.S. It also sheds light on disease course and outcomes.

Focus on Children

Information about GPA has been particularly limited for pediatric populations. Due to its relative rarity in children, much less has been known about the disease in this group, with studies limited to small cohorts. Earlier, smaller cohort studies had indicated potential differences in disease course and complication rates for pediatric versus adult populations.1

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Andrew J. White, MD, is the emeritus director of the division of pediatric rheuma­tology and the James P. Keating, MD, professor of pediatrics at Washington University in St. Louis, and one of the co-authors of the recent paper. Dr. White and his colleagues utilized a large private insurance claims data set of more than 99 million individuals to retrospectively characterize pediatric and adult GPA patients in the U.S. from 2006–2014. Patients were identified by medical claims forms using the diagnostic code for GPA.1 According to Dr. White, the research included data coded from both inpatient and outpatient encounters. “That’s different than a lot of these types of studies,” he says.

Overall, the researchers identified 5,566 cases of GPA. Of these, 3.8% (214) were pediatric cases. The incidence rate was 12.8 cases per million person-years in working-age adults (i.e., less than age 65), with a lower rate of 1.8 cases per million person-years for children.1

Dr. White

Dr. White

Dr. White says this is roughly consistent with previous estimates. The adult rate is comparable to that of a smaller report from the United Kingdom that reported a rate of 14.0 per million person-years.2 The pediatric rate was also in line with two other much smaller studies that found incidence rates of 2.8 and 0.9 cases per million person-years.2,3

The researchers also studied complication rates. Both children and working-age adults had high rates of hospitalizations and severe infections. “We found that the most common complications were being hospitalized, having a severe infection and having hematologic abnormalities such as cytopenias,” says Dr. White. “We found that hospitalizations were a little more common in children. Of the severe infections, they were mostly of the respiratory tract—pneumonias. The hematologic complications were more common in children than adults as well.” In fact, children had two to three times higher rates of leukopenia, neutropenia and hypogammaglobulinemia. Pulmonary infections occurred at a rate of approximately 50 infections per 1,000 person-years in both groups.1

Page: 1 2 3 | Single Page
Share: 

Filed under:Vasculitis Tagged with:granulomatosis with polyangiitisWegener's Granulomatosis

Related Articles
    Figure 2: Renal Biopsy

    The Classification & Diagnosis of Granulomatosis with Polyangiitis

    August 16, 2018

    Based on the classification system developed by the Chapel Hill Consensus Conference, anti-neutrophil cytoplasmic antibody (ANCA) associated vasculitis is defined as a necrotizing vasculitis involving small vessels that is associated with myeloperoxidase (MPO) ANCA or proteinase 3 (PR3) ANCA and displays minimal immune deposits. The mechanism behind the pathogenesis of ANCA-associated vasculitis is not fully…

    Figure 1. A nasal biopsy shows intimal infiltration of the small blood vessels (black arrow).

    Case Illustrates the Difficulty Diagnosing Granulomatosis with Polyangiitis

    June 21, 2018

    Granulomatosis with polyangiitis (GPA) was first described in the British Medical Journal in 1897 by Scottish otolaryngologist Peter McBride.1 GPA is a relatively rare, systemic necrotizing vasculitis that can make diagnosis challenging. The incidence has been estimated anywhere between two and 12 cases per million.2 GPA mainly affects adults between the ages of 45 and…

    Case Report: GPA or IgG4-Related Disease in an 11-Year-Old Girl?

    April 7, 2023

    Granulomatosis with polyangiitis (GPA) is a type of anti-neutrophil cytoplasmic antibody (ANCA) associated small vessel vasculitis that typically affects the kidneys, lungs and sinuses.1 Due to an overlap in signs and symptoms, GPA may initially be difficult to distinguish from IgG4-related disease, another condition that can affect multiple tissues and has variable presentations. Further complicating…

    Granulomatosis with Polyangiitis: A Case Review

    September 1, 2014

    Diagnosis, treatment and management of refractory gastrointestinal hemorrhage in a patient with GPA

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences